nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—ORM1—Vandetanib—thyroid cancer	0.169	0.236	CbGbCtD
Quinidine—ABCB11—Doxorubicin—thyroid cancer	0.0796	0.111	CbGbCtD
Quinidine—ABCC2—Sorafenib—thyroid cancer	0.069	0.096	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.046	0.0641	CbGbCtD
Quinidine—CYP3A7—Sorafenib—thyroid cancer	0.046	0.0641	CbGbCtD
Quinidine—CYP2B6—Sorafenib—thyroid cancer	0.0438	0.061	CbGbCtD
Quinidine—ABCC2—Doxorubicin—thyroid cancer	0.0418	0.0582	CbGbCtD
Quinidine—CYP2C8—Sorafenib—thyroid cancer	0.0332	0.0462	CbGbCtD
Quinidine—CYP2B6—Doxorubicin—thyroid cancer	0.0266	0.037	CbGbCtD
Quinidine—CYP1A2—Sorafenib—thyroid cancer	0.0257	0.0358	CbGbCtD
Quinidine—CYP2C9—Sorafenib—thyroid cancer	0.0232	0.0322	CbGbCtD
Quinidine—ABCB1—Sorafenib—thyroid cancer	0.0225	0.0313	CbGbCtD
Quinidine—CYP3A4—Vandetanib—thyroid cancer	0.0223	0.0311	CbGbCtD
Quinidine—CYP2D6—Sorafenib—thyroid cancer	0.0212	0.0295	CbGbCtD
Quinidine—ABCB1—Doxorubicin—thyroid cancer	0.0136	0.019	CbGbCtD
Quinidine—CYP3A4—Sorafenib—thyroid cancer	0.0135	0.0187	CbGbCtD
Quinidine—CYP2D6—Doxorubicin—thyroid cancer	0.0129	0.0179	CbGbCtD
Quinidine—CYP3A4—Doxorubicin—thyroid cancer	0.00817	0.0114	CbGbCtD
Quinidine—SLC22A4—larynx—thyroid cancer	0.00708	0.166	CbGeAlD
Quinidine—KCNK6—head—thyroid cancer	0.00341	0.08	CbGeAlD
Quinidine—KCNK1—saliva-secreting gland—thyroid cancer	0.00279	0.0654	CbGeAlD
Quinidine—KCNK1—trachea—thyroid cancer	0.00215	0.0505	CbGeAlD
Quinidine—SLC22A4—neck—thyroid cancer	0.00188	0.044	CbGeAlD
Quinidine—KCNK1—thyroid gland—thyroid cancer	0.0017	0.0399	CbGeAlD
Quinidine—KCNK1—head—thyroid cancer	0.00151	0.0354	CbGeAlD
Quinidine—SLC22A4—trachea—thyroid cancer	0.00113	0.0265	CbGeAlD
Quinidine—SCN1A—head—thyroid cancer	0.00112	0.0263	CbGeAlD
Quinidine—KCNK1—lymph node—thyroid cancer	0.00106	0.0248	CbGeAlD
Quinidine—SCN2A—head—thyroid cancer	0.00103	0.0241	CbGeAlD
Quinidine—SCN3A—thyroid gland—thyroid cancer	0.00102	0.0239	CbGeAlD
Quinidine—SLC22A5—saliva-secreting gland—thyroid cancer	0.000969	0.0227	CbGeAlD
Quinidine—SCN3A—head—thyroid cancer	0.000906	0.0212	CbGeAlD
Quinidine—SCN5A—head—thyroid cancer	0.000903	0.0212	CbGeAlD
Quinidine—SLC22A4—thyroid gland—thyroid cancer	0.000894	0.0209	CbGeAlD
Quinidine—Cardiac disorder—Sorafenib—thyroid cancer	0.000775	0.00384	CcSEcCtD
Quinidine—Flushing—Sorafenib—thyroid cancer	0.000775	0.00384	CcSEcCtD
Quinidine—CHRM2—head—thyroid cancer	0.000769	0.018	CbGeAlD
Quinidine—Decreased appetite—Vandetanib—thyroid cancer	0.000764	0.00379	CcSEcCtD
Quinidine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000759	0.00376	CcSEcCtD
Quinidine—SLC22A1—head—thyroid cancer	0.000755	0.0177	CbGeAlD
Quinidine—Immune system disorder—Sorafenib—thyroid cancer	0.000754	0.00374	CcSEcCtD
Quinidine—Mediastinal disorder—Sorafenib—thyroid cancer	0.000752	0.00373	CcSEcCtD
Quinidine—Scotoma—Doxorubicin—thyroid cancer	0.000749	0.00371	CcSEcCtD
Quinidine—SLC22A5—trachea—thyroid cancer	0.000748	0.0175	CbGeAlD
Quinidine—Petechiae—Epirubicin—thyroid cancer	0.000747	0.0037	CcSEcCtD
Quinidine—Mental disorder—Sorafenib—thyroid cancer	0.000731	0.00363	CcSEcCtD
Quinidine—SLCO1A2—head—thyroid cancer	0.000727	0.017	CbGeAlD
Quinidine—Erythema—Sorafenib—thyroid cancer	0.000727	0.0036	CcSEcCtD
Quinidine—Malnutrition—Sorafenib—thyroid cancer	0.000727	0.0036	CcSEcCtD
Quinidine—Necrosis—Doxorubicin—thyroid cancer	0.000724	0.00359	CcSEcCtD
Quinidine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000719	0.00357	CcSEcCtD
Quinidine—Vasodilation procedure—Epirubicin—thyroid cancer	0.000699	0.00347	CcSEcCtD
Quinidine—Vasodilation—Epirubicin—thyroid cancer	0.000699	0.00347	CcSEcCtD
Quinidine—Abdominal pain—Vandetanib—thyroid cancer	0.000695	0.00345	CcSEcCtD
Quinidine—Body temperature increased—Vandetanib—thyroid cancer	0.000695	0.00345	CcSEcCtD
Quinidine—SLC22A8—head—thyroid cancer	0.000694	0.0163	CbGeAlD
Quinidine—Petechiae—Doxorubicin—thyroid cancer	0.000691	0.00343	CcSEcCtD
Quinidine—Bone disorder—Epirubicin—thyroid cancer	0.00068	0.00337	CcSEcCtD
Quinidine—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00068	0.00337	CcSEcCtD
Quinidine—CYP1A1—trachea—thyroid cancer	0.000668	0.0157	CbGeAlD
Quinidine—Oliguria—Epirubicin—thyroid cancer	0.000667	0.00331	CcSEcCtD
Quinidine—Angioedema—Sorafenib—thyroid cancer	0.000664	0.00329	CcSEcCtD
Quinidine—Syncope—Sorafenib—thyroid cancer	0.000652	0.00323	CcSEcCtD
Quinidine—Leukopenia—Sorafenib—thyroid cancer	0.000651	0.00323	CcSEcCtD
Quinidine—Vasodilation—Doxorubicin—thyroid cancer	0.000647	0.00321	CcSEcCtD
Quinidine—Vasodilation procedure—Doxorubicin—thyroid cancer	0.000647	0.00321	CcSEcCtD
Quinidine—Loss of consciousness—Sorafenib—thyroid cancer	0.000639	0.00317	CcSEcCtD
Quinidine—SCN3A—lymph node—thyroid cancer	0.000634	0.0149	CbGeAlD
Quinidine—Atrioventricular block—Epirubicin—thyroid cancer	0.000633	0.00314	CcSEcCtD
Quinidine—Asthenia—Vandetanib—thyroid cancer	0.000631	0.00313	CcSEcCtD
Quinidine—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.000629	0.00312	CcSEcCtD
Quinidine—Bone disorder—Doxorubicin—thyroid cancer	0.000629	0.00312	CcSEcCtD
Quinidine—Pruritus—Vandetanib—thyroid cancer	0.000622	0.00308	CcSEcCtD
Quinidine—Myalgia—Sorafenib—thyroid cancer	0.000619	0.00307	CcSEcCtD
Quinidine—Oliguria—Doxorubicin—thyroid cancer	0.000617	0.00306	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000614	0.00305	CcSEcCtD
Quinidine—Ventricular tachycardia—Epirubicin—thyroid cancer	0.000614	0.00305	CcSEcCtD
Quinidine—Dermatitis contact—Epirubicin—thyroid cancer	0.000607	0.00301	CcSEcCtD
Quinidine—Diarrhoea—Vandetanib—thyroid cancer	0.000602	0.00298	CcSEcCtD
Quinidine—SLC22A5—thyroid gland—thyroid cancer	0.000592	0.0139	CbGeAlD
Quinidine—Atrioventricular block—Doxorubicin—thyroid cancer	0.000586	0.00291	CcSEcCtD
Quinidine—Shock—Sorafenib—thyroid cancer	0.000584	0.00289	CcSEcCtD
Quinidine—Nervous system disorder—Sorafenib—thyroid cancer	0.000582	0.00288	CcSEcCtD
Quinidine—Dizziness—Vandetanib—thyroid cancer	0.000581	0.00288	CcSEcCtD
Quinidine—Thrombocytopenia—Sorafenib—thyroid cancer	0.000581	0.00288	CcSEcCtD
Quinidine—ORM1—lymph node—thyroid cancer	0.000577	0.0135	CbGeAlD
Quinidine—Aplastic anaemia—Epirubicin—thyroid cancer	0.000577	0.00286	CcSEcCtD
Quinidine—Skin disorder—Sorafenib—thyroid cancer	0.000576	0.00286	CcSEcCtD
Quinidine—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.000568	0.00282	CcSEcCtD
Quinidine—Anorexia—Sorafenib—thyroid cancer	0.000565	0.0028	CcSEcCtD
Quinidine—Dermatitis contact—Doxorubicin—thyroid cancer	0.000562	0.00279	CcSEcCtD
Quinidine—Oesophagitis—Epirubicin—thyroid cancer	0.000561	0.00278	CcSEcCtD
Quinidine—Coma—Epirubicin—thyroid cancer	0.000561	0.00278	CcSEcCtD
Quinidine—Vomiting—Vandetanib—thyroid cancer	0.000559	0.00277	CcSEcCtD
Quinidine—Ecchymosis—Epirubicin—thyroid cancer	0.000555	0.00275	CcSEcCtD
Quinidine—SLC22A4—lymph node—thyroid cancer	0.000555	0.013	CbGeAlD
Quinidine—KCNH2—head—thyroid cancer	0.000555	0.013	CbGeAlD
Quinidine—Rash—Vandetanib—thyroid cancer	0.000554	0.00275	CcSEcCtD
Quinidine—Dermatitis—Vandetanib—thyroid cancer	0.000554	0.00275	CcSEcCtD
Quinidine—Headache—Vandetanib—thyroid cancer	0.000551	0.00273	CcSEcCtD
Quinidine—Pulmonary oedema—Epirubicin—thyroid cancer	0.000547	0.00271	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00054	0.00268	CcSEcCtD
Quinidine—CYP1A2—thyroid gland—thyroid cancer	0.000536	0.0126	CbGeAlD
Quinidine—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000534	0.00265	CcSEcCtD
Quinidine—Dyspnoea—Sorafenib—thyroid cancer	0.000529	0.00262	CcSEcCtD
Quinidine—CYP1A1—thyroid gland—thyroid cancer	0.000529	0.0124	CbGeAlD
Quinidine—Nausea—Vandetanib—thyroid cancer	0.000522	0.00259	CcSEcCtD
Quinidine—Oesophagitis—Doxorubicin—thyroid cancer	0.000519	0.00258	CcSEcCtD
Quinidine—Coma—Doxorubicin—thyroid cancer	0.000519	0.00258	CcSEcCtD
Quinidine—Decreased appetite—Sorafenib—thyroid cancer	0.000516	0.00256	CcSEcCtD
Quinidine—Ecchymosis—Doxorubicin—thyroid cancer	0.000514	0.00255	CcSEcCtD
Quinidine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000512	0.00254	CcSEcCtD
Quinidine—Photosensitivity—Epirubicin—thyroid cancer	0.000508	0.00252	CcSEcCtD
Quinidine—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000506	0.00251	CcSEcCtD
Quinidine—Eczema—Epirubicin—thyroid cancer	0.000496	0.00246	CcSEcCtD
Quinidine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000485	0.00241	CcSEcCtD
Quinidine—Renal failure acute—Epirubicin—thyroid cancer	0.000483	0.0024	CcSEcCtD
Quinidine—CYP2E1—thyroid gland—thyroid cancer	0.000482	0.0113	CbGeAlD
Quinidine—ABCC2—lymph node—thyroid cancer	0.000474	0.0111	CbGeAlD
Quinidine—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000473	0.00234	CcSEcCtD
Quinidine—Urticaria—Sorafenib—thyroid cancer	0.000471	0.00234	CcSEcCtD
Quinidine—Photosensitivity—Doxorubicin—thyroid cancer	0.00047	0.00233	CcSEcCtD
Quinidine—CYP1A1—head—thyroid cancer	0.000469	0.011	CbGeAlD
Quinidine—Abdominal pain—Sorafenib—thyroid cancer	0.000469	0.00233	CcSEcCtD
Quinidine—Body temperature increased—Sorafenib—thyroid cancer	0.000469	0.00233	CcSEcCtD
Quinidine—Renal impairment—Epirubicin—thyroid cancer	0.000469	0.00232	CcSEcCtD
Quinidine—Dermatitis bullous—Epirubicin—thyroid cancer	0.000467	0.00231	CcSEcCtD
Quinidine—Purpura—Epirubicin—thyroid cancer	0.000463	0.00229	CcSEcCtD
Quinidine—Eczema—Doxorubicin—thyroid cancer	0.000459	0.00228	CcSEcCtD
Quinidine—Hypoglycaemia—Epirubicin—thyroid cancer	0.000457	0.00227	CcSEcCtD
Quinidine—CYP2B6—head—thyroid cancer	0.000456	0.0107	CbGeAlD
Quinidine—Renal failure acute—Doxorubicin—thyroid cancer	0.000447	0.00222	CcSEcCtD
Quinidine—Diplopia—Epirubicin—thyroid cancer	0.000446	0.00221	CcSEcCtD
Quinidine—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000437	0.00217	CcSEcCtD
Quinidine—Hypersensitivity—Sorafenib—thyroid cancer	0.000437	0.00217	CcSEcCtD
Quinidine—Renal impairment—Doxorubicin—thyroid cancer	0.000434	0.00215	CcSEcCtD
Quinidine—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000432	0.00214	CcSEcCtD
Quinidine—Purpura—Doxorubicin—thyroid cancer	0.000428	0.00212	CcSEcCtD
Quinidine—CYP2E1—head—thyroid cancer	0.000428	0.01	CbGeAlD
Quinidine—Asthenia—Sorafenib—thyroid cancer	0.000426	0.00211	CcSEcCtD
Quinidine—Cardiac arrest—Epirubicin—thyroid cancer	0.000424	0.0021	CcSEcCtD
Quinidine—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000423	0.0021	CcSEcCtD
Quinidine—Pruritus—Sorafenib—thyroid cancer	0.00042	0.00208	CcSEcCtD
Quinidine—Ataxia—Epirubicin—thyroid cancer	0.000419	0.00208	CcSEcCtD
Quinidine—Diplopia—Doxorubicin—thyroid cancer	0.000413	0.00205	CcSEcCtD
Quinidine—Liver function test abnormal—Epirubicin—thyroid cancer	0.000412	0.00204	CcSEcCtD
Quinidine—Abdominal pain upper—Epirubicin—thyroid cancer	0.000407	0.00202	CcSEcCtD
Quinidine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000407	0.00202	CcSEcCtD
Quinidine—Diarrhoea—Sorafenib—thyroid cancer	0.000406	0.00201	CcSEcCtD
Quinidine—Breast disorder—Epirubicin—thyroid cancer	0.000403	0.002	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000402	0.00199	CcSEcCtD
Quinidine—Muscular weakness—Epirubicin—thyroid cancer	0.000393	0.00195	CcSEcCtD
Quinidine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000392	0.00195	CcSEcCtD
Quinidine—Dizziness—Sorafenib—thyroid cancer	0.000392	0.00194	CcSEcCtD
Quinidine—KCNH2—lymph node—thyroid cancer	0.000389	0.00911	CbGeAlD
Quinidine—Ataxia—Doxorubicin—thyroid cancer	0.000388	0.00192	CcSEcCtD
Quinidine—Asthma—Epirubicin—thyroid cancer	0.000385	0.00191	CcSEcCtD
Quinidine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000381	0.00189	CcSEcCtD
Quinidine—Vomiting—Sorafenib—thyroid cancer	0.000377	0.00187	CcSEcCtD
Quinidine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000377	0.00187	CcSEcCtD
Quinidine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000377	0.00187	CcSEcCtD
Quinidine—Angina pectoris—Epirubicin—thyroid cancer	0.000375	0.00186	CcSEcCtD
Quinidine—Rash—Sorafenib—thyroid cancer	0.000374	0.00185	CcSEcCtD
Quinidine—Dermatitis—Sorafenib—thyroid cancer	0.000374	0.00185	CcSEcCtD
Quinidine—Breast disorder—Doxorubicin—thyroid cancer	0.000373	0.00185	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000372	0.00184	CcSEcCtD
Quinidine—Headache—Sorafenib—thyroid cancer	0.000372	0.00184	CcSEcCtD
Quinidine—SLC22A5—lymph node—thyroid cancer	0.000367	0.00861	CbGeAlD
Quinidine—Pancytopenia—Epirubicin—thyroid cancer	0.000366	0.00182	CcSEcCtD
Quinidine—Muscular weakness—Doxorubicin—thyroid cancer	0.000364	0.0018	CcSEcCtD
Quinidine—Neutropenia—Epirubicin—thyroid cancer	0.00036	0.00179	CcSEcCtD
Quinidine—Asthma—Doxorubicin—thyroid cancer	0.000357	0.00177	CcSEcCtD
Quinidine—Nausea—Sorafenib—thyroid cancer	0.000352	0.00175	CcSEcCtD
Quinidine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000352	0.00174	CcSEcCtD
Quinidine—Angina pectoris—Doxorubicin—thyroid cancer	0.000347	0.00172	CcSEcCtD
Quinidine—ABCB1—trachea—thyroid cancer	0.000347	0.00813	CbGeAlD
Quinidine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000341	0.00169	CcSEcCtD
Quinidine—Pancytopenia—Doxorubicin—thyroid cancer	0.000339	0.00168	CcSEcCtD
Quinidine—CYP2D6—head—thyroid cancer	0.000339	0.00793	CbGeAlD
Quinidine—Renal failure—Epirubicin—thyroid cancer	0.000338	0.00168	CcSEcCtD
Quinidine—Jaundice—Epirubicin—thyroid cancer	0.000335	0.00166	CcSEcCtD
Quinidine—Neutropenia—Doxorubicin—thyroid cancer	0.000334	0.00165	CcSEcCtD
Quinidine—Sweating—Epirubicin—thyroid cancer	0.000329	0.00163	CcSEcCtD
Quinidine—CYP1A1—lymph node—thyroid cancer	0.000328	0.00769	CbGeAlD
Quinidine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000326	0.00161	CcSEcCtD
Quinidine—Agranulocytosis—Epirubicin—thyroid cancer	0.000321	0.00159	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000315	0.00156	CcSEcCtD
Quinidine—Bradycardia—Epirubicin—thyroid cancer	0.000314	0.00156	CcSEcCtD
Quinidine—Renal failure—Doxorubicin—thyroid cancer	0.000313	0.00155	CcSEcCtD
Quinidine—Haemoglobin—Epirubicin—thyroid cancer	0.00031	0.00154	CcSEcCtD
Quinidine—Jaundice—Doxorubicin—thyroid cancer	0.00031	0.00154	CcSEcCtD
Quinidine—Hepatitis—Epirubicin—thyroid cancer	0.000309	0.00153	CcSEcCtD
Quinidine—Haemorrhage—Epirubicin—thyroid cancer	0.000309	0.00153	CcSEcCtD
Quinidine—Sweating—Doxorubicin—thyroid cancer	0.000305	0.00151	CcSEcCtD
Quinidine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000305	0.00151	CcSEcCtD
Quinidine—Urethral disorder—Epirubicin—thyroid cancer	0.000302	0.0015	CcSEcCtD
Quinidine—Visual impairment—Epirubicin—thyroid cancer	0.000297	0.00147	CcSEcCtD
Quinidine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000297	0.00147	CcSEcCtD
Quinidine—Erythema multiforme—Epirubicin—thyroid cancer	0.000292	0.00145	CcSEcCtD
Quinidine—Bradycardia—Doxorubicin—thyroid cancer	0.000291	0.00144	CcSEcCtD
Quinidine—Eye disorder—Epirubicin—thyroid cancer	0.000288	0.00143	CcSEcCtD
Quinidine—Tinnitus—Epirubicin—thyroid cancer	0.000288	0.00143	CcSEcCtD
Quinidine—Haemoglobin—Doxorubicin—thyroid cancer	0.000287	0.00142	CcSEcCtD
Quinidine—Flushing—Epirubicin—thyroid cancer	0.000286	0.00142	CcSEcCtD
Quinidine—Cardiac disorder—Epirubicin—thyroid cancer	0.000286	0.00142	CcSEcCtD
Quinidine—Haemorrhage—Doxorubicin—thyroid cancer	0.000285	0.00142	CcSEcCtD
Quinidine—Hepatitis—Doxorubicin—thyroid cancer	0.000285	0.00142	CcSEcCtD
Quinidine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000282	0.0014	CcSEcCtD
Quinidine—Urethral disorder—Doxorubicin—thyroid cancer	0.00028	0.00139	CcSEcCtD
Quinidine—Immune system disorder—Epirubicin—thyroid cancer	0.000279	0.00138	CcSEcCtD
Quinidine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000278	0.00138	CcSEcCtD
Quinidine—Chills—Epirubicin—thyroid cancer	0.000277	0.00137	CcSEcCtD
Quinidine—Visual impairment—Doxorubicin—thyroid cancer	0.000275	0.00136	CcSEcCtD
Quinidine—ABCB1—thyroid gland—thyroid cancer	0.000275	0.00643	CbGeAlD
Quinidine—Mental disorder—Epirubicin—thyroid cancer	0.00027	0.00134	CcSEcCtD
Quinidine—Erythema multiforme—Doxorubicin—thyroid cancer	0.00027	0.00134	CcSEcCtD
Quinidine—Erythema—Epirubicin—thyroid cancer	0.000269	0.00133	CcSEcCtD
Quinidine—Malnutrition—Epirubicin—thyroid cancer	0.000269	0.00133	CcSEcCtD
Quinidine—Eye disorder—Doxorubicin—thyroid cancer	0.000267	0.00132	CcSEcCtD
Quinidine—Tinnitus—Doxorubicin—thyroid cancer	0.000266	0.00132	CcSEcCtD
Quinidine—Flushing—Doxorubicin—thyroid cancer	0.000265	0.00131	CcSEcCtD
Quinidine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000265	0.00131	CcSEcCtD
Quinidine—Immune system disorder—Doxorubicin—thyroid cancer	0.000258	0.00128	CcSEcCtD
Quinidine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000257	0.00128	CcSEcCtD
Quinidine—Chills—Doxorubicin—thyroid cancer	0.000256	0.00127	CcSEcCtD
Quinidine—Vision blurred—Epirubicin—thyroid cancer	0.000253	0.00126	CcSEcCtD
Quinidine—Mental disorder—Doxorubicin—thyroid cancer	0.00025	0.00124	CcSEcCtD
Quinidine—Malnutrition—Doxorubicin—thyroid cancer	0.000249	0.00123	CcSEcCtD
Quinidine—Erythema—Doxorubicin—thyroid cancer	0.000249	0.00123	CcSEcCtD
Quinidine—Agitation—Epirubicin—thyroid cancer	0.000247	0.00122	CcSEcCtD
Quinidine—ABCB1—head—thyroid cancer	0.000244	0.00571	CbGeAlD
Quinidine—Vertigo—Epirubicin—thyroid cancer	0.000241	0.0012	CcSEcCtD
Quinidine—Syncope—Epirubicin—thyroid cancer	0.000241	0.00119	CcSEcCtD
Quinidine—Leukopenia—Epirubicin—thyroid cancer	0.00024	0.00119	CcSEcCtD
Quinidine—Palpitations—Epirubicin—thyroid cancer	0.000237	0.00118	CcSEcCtD
Quinidine—Loss of consciousness—Epirubicin—thyroid cancer	0.000236	0.00117	CcSEcCtD
Quinidine—Vision blurred—Doxorubicin—thyroid cancer	0.000234	0.00116	CcSEcCtD
Quinidine—Convulsion—Epirubicin—thyroid cancer	0.000233	0.00115	CcSEcCtD
Quinidine—Chest pain—Epirubicin—thyroid cancer	0.000229	0.00113	CcSEcCtD
Quinidine—Myalgia—Epirubicin—thyroid cancer	0.000229	0.00113	CcSEcCtD
Quinidine—Agitation—Doxorubicin—thyroid cancer	0.000228	0.00113	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000227	0.00113	CcSEcCtD
Quinidine—Vertigo—Doxorubicin—thyroid cancer	0.000223	0.00111	CcSEcCtD
Quinidine—Syncope—Doxorubicin—thyroid cancer	0.000223	0.00111	CcSEcCtD
Quinidine—Leukopenia—Doxorubicin—thyroid cancer	0.000222	0.0011	CcSEcCtD
Quinidine—Confusional state—Epirubicin—thyroid cancer	0.000221	0.0011	CcSEcCtD
Quinidine—Palpitations—Doxorubicin—thyroid cancer	0.00022	0.00109	CcSEcCtD
Quinidine—Oedema—Epirubicin—thyroid cancer	0.000219	0.00109	CcSEcCtD
Quinidine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000218	0.00108	CcSEcCtD
Quinidine—Shock—Epirubicin—thyroid cancer	0.000216	0.00107	CcSEcCtD
Quinidine—Convulsion—Doxorubicin—thyroid cancer	0.000215	0.00107	CcSEcCtD
Quinidine—Nervous system disorder—Epirubicin—thyroid cancer	0.000215	0.00107	CcSEcCtD
Quinidine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000215	0.00106	CcSEcCtD
Quinidine—Tachycardia—Epirubicin—thyroid cancer	0.000214	0.00106	CcSEcCtD
Quinidine—Skin disorder—Epirubicin—thyroid cancer	0.000213	0.00106	CcSEcCtD
Quinidine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000212	0.00105	CcSEcCtD
Quinidine—Chest pain—Doxorubicin—thyroid cancer	0.000212	0.00105	CcSEcCtD
Quinidine—Myalgia—Doxorubicin—thyroid cancer	0.000212	0.00105	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00021	0.00104	CcSEcCtD
Quinidine—Anorexia—Epirubicin—thyroid cancer	0.000209	0.00104	CcSEcCtD
Quinidine—Hypotension—Epirubicin—thyroid cancer	0.000205	0.00102	CcSEcCtD
Quinidine—Confusional state—Doxorubicin—thyroid cancer	0.000205	0.00101	CcSEcCtD
Quinidine—Oedema—Doxorubicin—thyroid cancer	0.000203	0.00101	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.0002	0.00099	CcSEcCtD
Quinidine—Shock—Doxorubicin—thyroid cancer	0.0002	0.00099	CcSEcCtD
Quinidine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000199	0.000986	CcSEcCtD
Quinidine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000199	0.000985	CcSEcCtD
Quinidine—Tachycardia—Doxorubicin—thyroid cancer	0.000198	0.000982	CcSEcCtD
Quinidine—Skin disorder—Doxorubicin—thyroid cancer	0.000197	0.000977	CcSEcCtD
Quinidine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000196	0.000972	CcSEcCtD
Quinidine—Dyspnoea—Epirubicin—thyroid cancer	0.000195	0.000969	CcSEcCtD
Quinidine—Anorexia—Doxorubicin—thyroid cancer	0.000193	0.000959	CcSEcCtD
Quinidine—Decreased appetite—Epirubicin—thyroid cancer	0.000191	0.000945	CcSEcCtD
Quinidine—Hypotension—Doxorubicin—thyroid cancer	0.00019	0.00094	CcSEcCtD
Quinidine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000189	0.000938	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000185	0.000916	CcSEcCtD
Quinidine—Dyspnoea—Doxorubicin—thyroid cancer	0.000181	0.000897	CcSEcCtD
Quinidine—Feeling abnormal—Epirubicin—thyroid cancer	0.000181	0.000896	CcSEcCtD
Quinidine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000179	0.000889	CcSEcCtD
Quinidine—Decreased appetite—Doxorubicin—thyroid cancer	0.000176	0.000874	CcSEcCtD
Quinidine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000175	0.000868	CcSEcCtD
Quinidine—Urticaria—Epirubicin—thyroid cancer	0.000174	0.000864	CcSEcCtD
Quinidine—Body temperature increased—Epirubicin—thyroid cancer	0.000173	0.000859	CcSEcCtD
Quinidine—Abdominal pain—Epirubicin—thyroid cancer	0.000173	0.000859	CcSEcCtD
Quinidine—ABCB1—lymph node—thyroid cancer	0.000171	0.004	CbGeAlD
Quinidine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000167	0.000829	CcSEcCtD
Quinidine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000166	0.000822	CcSEcCtD
Quinidine—Hypersensitivity—Epirubicin—thyroid cancer	0.000161	0.000801	CcSEcCtD
Quinidine—Urticaria—Doxorubicin—thyroid cancer	0.000161	0.000799	CcSEcCtD
Quinidine—Body temperature increased—Doxorubicin—thyroid cancer	0.00016	0.000795	CcSEcCtD
Quinidine—Abdominal pain—Doxorubicin—thyroid cancer	0.00016	0.000795	CcSEcCtD
Quinidine—Asthenia—Epirubicin—thyroid cancer	0.000157	0.00078	CcSEcCtD
Quinidine—Pruritus—Epirubicin—thyroid cancer	0.000155	0.000769	CcSEcCtD
Quinidine—Diarrhoea—Epirubicin—thyroid cancer	0.00015	0.000744	CcSEcCtD
Quinidine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000149	0.000741	CcSEcCtD
Quinidine—Asthenia—Doxorubicin—thyroid cancer	0.000146	0.000722	CcSEcCtD
Quinidine—Dizziness—Epirubicin—thyroid cancer	0.000145	0.000719	CcSEcCtD
Quinidine—Pruritus—Doxorubicin—thyroid cancer	0.000143	0.000712	CcSEcCtD
Quinidine—Vomiting—Epirubicin—thyroid cancer	0.000139	0.000691	CcSEcCtD
Quinidine—Diarrhoea—Doxorubicin—thyroid cancer	0.000139	0.000688	CcSEcCtD
Quinidine—Rash—Epirubicin—thyroid cancer	0.000138	0.000685	CcSEcCtD
Quinidine—Dermatitis—Epirubicin—thyroid cancer	0.000138	0.000685	CcSEcCtD
Quinidine—Headache—Epirubicin—thyroid cancer	0.000137	0.000681	CcSEcCtD
Quinidine—Dizziness—Doxorubicin—thyroid cancer	0.000134	0.000665	CcSEcCtD
Quinidine—Nausea—Epirubicin—thyroid cancer	0.00013	0.000646	CcSEcCtD
Quinidine—Vomiting—Doxorubicin—thyroid cancer	0.000129	0.000639	CcSEcCtD
Quinidine—Rash—Doxorubicin—thyroid cancer	0.000128	0.000634	CcSEcCtD
Quinidine—Dermatitis—Doxorubicin—thyroid cancer	0.000128	0.000634	CcSEcCtD
Quinidine—Headache—Doxorubicin—thyroid cancer	0.000127	0.00063	CcSEcCtD
Quinidine—Nausea—Doxorubicin—thyroid cancer	0.00012	0.000597	CcSEcCtD
Quinidine—ABCB11—Metabolism—PRKAR1A—thyroid cancer	3.49e-05	0.000942	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—NRAS—thyroid cancer	3.46e-05	0.000933	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.46e-05	0.000933	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CHST14—thyroid cancer	3.43e-05	0.000925	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—MINPP1—thyroid cancer	3.43e-05	0.000924	CbGpPWpGaD
Quinidine—SCN1A—Axon guidance—HRAS—thyroid cancer	3.42e-05	0.000923	CbGpPWpGaD
Quinidine—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.4e-05	0.000918	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TRIM33—thyroid cancer	3.39e-05	0.000914	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—NDUFA13—thyroid cancer	3.35e-05	0.000902	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—NRAS—thyroid cancer	3.34e-05	0.0009	CbGpPWpGaD
Quinidine—SLC22A1—Neuronal System—BRAF—thyroid cancer	3.33e-05	0.000897	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—NRAS—thyroid cancer	3.29e-05	0.000887	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—MINPP1—thyroid cancer	3.23e-05	0.000871	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.2e-05	0.000864	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.17e-05	0.000854	CbGpPWpGaD
Quinidine—CHRM2—Regulation of Actin Cytoskeleton—NRAS—thyroid cancer	3.16e-05	0.000851	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CHST14—thyroid cancer	3.15e-05	0.000848	CbGpPWpGaD
Quinidine—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.12e-05	0.000841	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—KRAS—thyroid cancer	3.1e-05	0.000836	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—TSHR—thyroid cancer	3.09e-05	0.000832	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	3.03e-05	0.000816	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—HPGD—thyroid cancer	3e-05	0.000808	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—KRAS—thyroid cancer	2.98e-05	0.000803	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—TPR—thyroid cancer	2.96e-05	0.000799	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—HPGD—thyroid cancer	2.93e-05	0.000791	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	2.92e-05	0.000786	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—NDUFA13—thyroid cancer	2.92e-05	0.000786	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.91e-05	0.000784	CbGpPWpGaD
Quinidine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	2.88e-05	0.000775	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—KRAS—thyroid cancer	2.87e-05	0.000775	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—KRAS—thyroid cancer	2.83e-05	0.000763	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—TSHR—thyroid cancer	2.8e-05	0.000756	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—HPGD—thyroid cancer	2.77e-05	0.000746	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PRKAR1A—thyroid cancer	2.76e-05	0.000744	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	2.75e-05	0.000741	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CHST14—thyroid cancer	2.74e-05	0.000739	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—MINPP1—thyroid cancer	2.74e-05	0.000738	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—NDUFA13—thyroid cancer	2.72e-05	0.000734	CbGpPWpGaD
Quinidine—CHRM2—Regulation of Actin Cytoskeleton—KRAS—thyroid cancer	2.72e-05	0.000733	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	2.71e-05	0.000731	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	2.71e-05	0.000731	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.67e-05	0.000719	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—SLC5A5—thyroid cancer	2.66e-05	0.000717	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.64e-05	0.000713	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—HRAS—thyroid cancer	2.64e-05	0.000711	CbGpPWpGaD
Quinidine—KCNH2—Neuronal System—HRAS—thyroid cancer	2.63e-05	0.000709	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CHST14—thyroid cancer	2.58e-05	0.000696	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CHST14—thyroid cancer	2.56e-05	0.00069	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—HPGD—thyroid cancer	2.54e-05	0.000684	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—TPR—thyroid cancer	2.54e-05	0.000683	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—HRAS—thyroid cancer	2.53e-05	0.000683	CbGpPWpGaD
Quinidine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.51e-05	0.000676	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	2.49e-05	0.000672	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.49e-05	0.000672	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—HRAS—thyroid cancer	2.44e-05	0.000658	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—HRAS—thyroid cancer	2.41e-05	0.000649	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—SST—thyroid cancer	2.4e-05	0.000647	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—PTCH1—thyroid cancer	2.38e-05	0.000643	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—NRAS—thyroid cancer	2.35e-05	0.000633	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—AKT1—thyroid cancer	2.33e-05	0.000628	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—NDUFA13—thyroid cancer	2.33e-05	0.000628	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—TPR—thyroid cancer	2.33e-05	0.000627	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—TPR—thyroid cancer	2.32e-05	0.000626	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CALCA—thyroid cancer	2.31e-05	0.000623	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	2.29e-05	0.000617	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	2.29e-05	0.000616	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TCF7L1—thyroid cancer	2.26e-05	0.00061	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.26e-05	0.000609	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.24e-05	0.000605	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—AKT1—thyroid cancer	2.24e-05	0.000603	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—RXRA—thyroid cancer	2.23e-05	0.000602	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	2.22e-05	0.000598	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—HPGD—thyroid cancer	2.21e-05	0.000596	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CHST14—thyroid cancer	2.19e-05	0.00059	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—SST—thyroid cancer	2.18e-05	0.000588	CbGpPWpGaD
Quinidine—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.17e-05	0.000586	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—TPR—thyroid cancer	2.17e-05	0.000584	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—AKT1—thyroid cancer	2.16e-05	0.000581	CbGpPWpGaD
Quinidine—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	2.14e-05	0.000577	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.13e-05	0.000575	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	2.13e-05	0.000574	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.11e-05	0.00057	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CALCA—thyroid cancer	2.1e-05	0.000566	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—HPGD—thyroid cancer	2.08e-05	0.000561	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.08e-05	0.000561	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—HPGD—thyroid cancer	2.06e-05	0.000557	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.06e-05	0.000555	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.03e-05	0.000547	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—KRAS—thyroid cancer	2.02e-05	0.000545	CbGpPWpGaD
Quinidine—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	2e-05	0.000538	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.93e-05	0.000519	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CDK1—thyroid cancer	1.9e-05	0.000512	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	1.9e-05	0.000512	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—RXRA—thyroid cancer	1.86e-05	0.000503	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.86e-05	0.000501	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.81e-05	0.000489	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.8e-05	0.000484	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.78e-05	0.000479	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—HPGD—thyroid cancer	1.76e-05	0.000476	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.74e-05	0.00047	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—SLC5A5—thyroid cancer	1.74e-05	0.000469	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—TPR—thyroid cancer	1.72e-05	0.000464	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—HRAS—thyroid cancer	1.72e-05	0.000463	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.7e-05	0.000459	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	1.69e-05	0.000456	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CHST14—thyroid cancer	1.69e-05	0.000455	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—TPR—thyroid cancer	1.69e-05	0.000454	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.67e-05	0.000451	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	1.66e-05	0.000447	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TSHR—thyroid cancer	1.66e-05	0.000447	CbGpPWpGaD
Quinidine—SLC22A2—Neuronal System—HRAS—thyroid cancer	1.64e-05	0.000442	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PRKAR1A—thyroid cancer	1.63e-05	0.000439	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—SLC5A5—thyroid cancer	1.62e-05	0.000437	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—RXRA—thyroid cancer	1.59e-05	0.00043	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—TPR—thyroid cancer	1.59e-05	0.000428	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	1.56e-05	0.000421	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—MEN1—thyroid cancer	1.56e-05	0.00042	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.55e-05	0.000418	CbGpPWpGaD
Quinidine—SLC22A1—Neuronal System—HRAS—thyroid cancer	1.53e-05	0.000412	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—AKT1—thyroid cancer	1.52e-05	0.000409	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—RXRA—thyroid cancer	1.46e-05	0.000395	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—RXRA—thyroid cancer	1.46e-05	0.000394	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—TPR—thyroid cancer	1.46e-05	0.000393	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.43e-05	0.000386	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.43e-05	0.000386	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.43e-05	0.000385	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.42e-05	0.000382	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PPARG—thyroid cancer	1.41e-05	0.00038	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PTCH1—thyroid cancer	1.41e-05	0.00038	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—RXRA—thyroid cancer	1.36e-05	0.000367	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—HPGD—thyroid cancer	1.36e-05	0.000367	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.3e-05	0.00035	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—SLC5A5—thyroid cancer	1.29e-05	0.000347	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—SST—thyroid cancer	1.29e-05	0.000347	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—TPR—thyroid cancer	1.27e-05	0.000342	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.27e-05	0.000342	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—SLC5A5—thyroid cancer	1.26e-05	0.00034	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.25e-05	0.000337	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CALCA—thyroid cancer	1.24e-05	0.000334	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—TPR—thyroid cancer	1.2e-05	0.000322	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—SLC5A5—thyroid cancer	1.19e-05	0.000321	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—TPR—thyroid cancer	1.19e-05	0.00032	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PPARG—thyroid cancer	1.18e-05	0.000317	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.18e-05	0.000317	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.17e-05	0.000314	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CDK1—thyroid cancer	1.12e-05	0.000303	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.11e-05	0.000301	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PTGS2—thyroid cancer	1.11e-05	0.000299	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.09e-05	0.000294	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—RXRA—thyroid cancer	1.08e-05	0.000292	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.07e-05	0.000289	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—RXRA—thyroid cancer	1.06e-05	0.000286	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.06e-05	0.000285	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.02e-05	0.000275	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—TPR—thyroid cancer	1.01e-05	0.000273	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.01e-05	0.000271	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—RXRA—thyroid cancer	9.99e-06	0.000269	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	9.97e-06	0.000269	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.72e-06	0.000262	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—PTEN—thyroid cancer	9.67e-06	0.000261	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—SLC5A5—thyroid cancer	9.5e-06	0.000256	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PTGS2—thyroid cancer	9.26e-06	0.00025	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PPARG—thyroid cancer	9.24e-06	0.000249	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PPARG—thyroid cancer	9.23e-06	0.000249	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—RXRA—thyroid cancer	9.16e-06	0.000247	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.03e-06	0.000244	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NRG1—thyroid cancer	9.01e-06	0.000243	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	8.95e-06	0.000241	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.91e-06	0.00024	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	8.88e-06	0.000239	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PPARG—thyroid cancer	8.6e-06	0.000232	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.32e-06	0.000224	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TERT—thyroid cancer	8.09e-06	0.000218	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—PTEN—thyroid cancer	8.08e-06	0.000218	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—RXRA—thyroid cancer	7.98e-06	0.000215	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTGS2—thyroid cancer	7.92e-06	0.000214	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—TPR—thyroid cancer	7.82e-06	0.000211	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HIF1A—thyroid cancer	7.74e-06	0.000209	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	7.69e-06	0.000207	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	7.58e-06	0.000204	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—RXRA—thyroid cancer	7.52e-06	0.000203	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—RXRA—thyroid cancer	7.46e-06	0.000201	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTGS2—thyroid cancer	7.27e-06	0.000196	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTGS2—thyroid cancer	7.26e-06	0.000196	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.25e-06	0.000196	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.11e-06	0.000192	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—PTEN—thyroid cancer	6.91e-06	0.000186	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PPARG—thyroid cancer	6.83e-06	0.000184	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—NRAS—thyroid cancer	6.81e-06	0.000184	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTGS2—thyroid cancer	6.76e-06	0.000182	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PPARG—thyroid cancer	6.69e-06	0.00018	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—BRAF—thyroid cancer	6.41e-06	0.000173	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—RXRA—thyroid cancer	6.37e-06	0.000172	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—PTEN—thyroid cancer	6.34e-06	0.000171	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—PTEN—thyroid cancer	6.33e-06	0.000171	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PPARG—thyroid cancer	6.31e-06	0.00017	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.2e-06	0.000167	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—PTEN—thyroid cancer	5.9e-06	0.000159	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—KRAS—thyroid cancer	5.87e-06	0.000158	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	5.85e-06	0.000158	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PPARG—thyroid cancer	5.78e-06	0.000156	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—AKT1—thyroid cancer	5.58e-06	0.00015	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTGS2—thyroid cancer	5.38e-06	0.000145	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTGS2—thyroid cancer	5.26e-06	0.000142	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PPARG—thyroid cancer	5.04e-06	0.000136	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HRAS—thyroid cancer	4.99e-06	0.000134	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTGS2—thyroid cancer	4.96e-06	0.000134	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—RXRA—thyroid cancer	4.92e-06	0.000133	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—AKT1—thyroid cancer	4.85e-06	0.000131	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PPARG—thyroid cancer	4.75e-06	0.000128	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PPARG—thyroid cancer	4.71e-06	0.000127	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—PTEN—thyroid cancer	4.69e-06	0.000126	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CCND1—thyroid cancer	4.67e-06	0.000126	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—AKT1—thyroid cancer	4.65e-06	0.000125	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—PTEN—thyroid cancer	4.59e-06	0.000124	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTGS2—thyroid cancer	4.55e-06	0.000123	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PTEN—thyroid cancer	4.51e-06	0.000122	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—AKT1—thyroid cancer	4.4e-06	0.000119	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—PTEN—thyroid cancer	4.33e-06	0.000117	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NRAS—thyroid cancer	4.03e-06	0.000109	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PPARG—thyroid cancer	4.02e-06	0.000108	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—AKT1—thyroid cancer	3.98e-06	0.000107	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—PTEN—thyroid cancer	3.97e-06	0.000107	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTGS2—thyroid cancer	3.96e-06	0.000107	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTGS2—thyroid cancer	3.74e-06	0.000101	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTGS2—thyroid cancer	3.7e-06	9.99e-05	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—AKT1—thyroid cancer	3.65e-06	9.85e-05	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—AKT1—thyroid cancer	3.65e-06	9.83e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—KRAS—thyroid cancer	3.46e-06	9.34e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—PTEN—thyroid cancer	3.46e-06	9.32e-05	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—AKT1—thyroid cancer	3.4e-06	9.17e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—PTEN—thyroid cancer	3.26e-06	8.78e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—PTEN—thyroid cancer	3.23e-06	8.71e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTGS2—thyroid cancer	3.16e-06	8.53e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PPARG—thyroid cancer	3.11e-06	8.37e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TP53—thyroid cancer	3.08e-06	8.3e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HRAS—thyroid cancer	2.95e-06	7.94e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—PTEN—thyroid cancer	2.76e-06	7.44e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—AKT1—thyroid cancer	2.7e-06	7.28e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—AKT1—thyroid cancer	2.65e-06	7.13e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—AKT1—thyroid cancer	2.6e-06	7.01e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—AKT1—thyroid cancer	2.49e-06	6.73e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.44e-06	6.59e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—AKT1—thyroid cancer	2.29e-06	6.17e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—PTEN—thyroid cancer	2.13e-06	5.74e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—AKT1—thyroid cancer	1.99e-06	5.37e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—AKT1—thyroid cancer	1.88e-06	5.06e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—AKT1—thyroid cancer	1.86e-06	5.02e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—AKT1—thyroid cancer	1.59e-06	4.29e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—AKT1—thyroid cancer	1.23e-06	3.31e-05	CbGpPWpGaD
